Recombinant Factor VIIa May Be Effective for Acute-Onset Intracerebral Hemorrhage

In a randomized study, treatment within four hours limited hematoma growth, reduced mortality, and improved functional outcomes at 90 days, despite an increase in thromboembolic events.Laurie Barclay

Continue to Recombinant Factor VIIa May Be Effective for Acute-Onset Intracerebral Hemorrhage on Medscape Headlines.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz